Rate My Professor mark abzug

Mark J. Abzug, MD, is Professor of Pediatrics in the Section of Pediatric Infectious Diseases at the University of Colorado Anschutz Medical Campus, part of the University of Colorado Denver School of Medicine. He holds the position of Vice Chair for Academic Affairs in the Department of Pediatrics, where he provides counseling to faculty on academic rank and advancement, midpoint reviews, promotion, and tenure processes. He also serves as Co-Chair of the Department of Pediatrics Promotions and Tenure Committee. Abzug received his MD from Boston University School of Medicine in 1982. He completed his internship in 1983 and pediatric residency in 1985 at Strong Memorial Hospital of the University of Rochester, followed by a fellowship in Pediatric Infectious Diseases at the University of Colorado University Hospital Program in 1988. He is board certified in Pediatrics since 1986 and in Pediatric Infectious Diseases since 1994.

Abzug directs clinical research on viral infections, infections in immunocompromised patients, and pediatric HIV infection. He participates in national collaborative clinical trials of antiviral therapies through the National Institutes of Health Collaborative Antiviral Study Group and the International Maternal Pediatric Adolescent AIDS Clinical Trials Network. His clinical interests include perinatal infections, enterovirus infections, and infections in immunocompromised patients. He served as Principal Investigator on an NIH-funded grant (R29HD027692) from 1991 to 1997 studying enterovirus infections of the placenta and fetus. Abzug has contributed extensively to the literature, serving as an editor for Current Diagnosis and Treatment: Pediatrics, 27th edition (2025), and authoring chapters in Plotkin’s Vaccines, 8th edition (2024), Nelson Textbook of Pediatrics, 22nd edition (2024), Principles and Practice of Pediatric Infectious Diseases, 6th edition (2023), and Red Book: 2024 Report of the Committee on Infectious Diseases, 33rd edition (2024). Recent peer-reviewed publications include 'Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis' (Journal of the Pediatric Infectious Diseases Society, 2024), 'Guidance for prevention and management of COVID-19 in children and adolescents' (Journal of the Pediatric Infectious Diseases Society, 2024), and 'Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children' (Journal of the Pediatric Infectious Diseases Society, 2023). Earlier works address enterovirus sepsis, acute flaccid myelitis, and HIV-related outcomes in youth.